peptides

  • EBV Latent membrane protein 2  345-352, CPLSKILL

    EBV Latent membrane protein 2 345-352, CPLSKILL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-CPLSKILL-OH Specifications: 8mer peptide as TFA salt

  • EBV Latent membrane protein 2  453-461, LTAGFLIFL

    EBV Latent membrane protein 2 453-461, LTAGFLIFL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LTAGFLIFL-OH Specifications: 9mer peptide as TFA salt

  • EBV LMP2 131-139 Peptide (HLA-A*24:02) - PYLFWLAAI

    EBV LMP2 131-139 Peptide (HLA-A*24:02) – PYLFWLAAI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 2 (LMP2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-PYLFWLAAI-OH Specifications: 9mer peptide as TFA salt

  • EBV LMP2 200-208 Peptide (HLA-B*40:01) - IEDPPFNSL

    EBV LMP2 200-208 Peptide (HLA-B*40:01) – IEDPPFNSL

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 2 (LMP2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-IEDPPFNSL-OH

  • EBV LMP2 340-349 Peptide - SSCSSCPLSK

    EBV LMP2 340-349 Peptide – SSCSSCPLSK

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SSCSSCPLSK-OH Specifications: 10mer peptide as TFA salt

  • EBV LMP2 356-364 Peptide (HLA-A*02:01) - FLYALALLL

    EBV LMP2 356-364 Peptide (HLA-A*02:01) – FLYALALLL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 2 (LMP2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FLYALALLL-OH Specifications: 9mer peptide as TFA salt

  • EBV LMP2 419-427 Peptide (HLA-A*24:02) - TYGPVFMCL

    EBV LMP2 419-427 Peptide (HLA-A*24:02) – TYGPVFMCL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 2 (LMP2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TYGPVFMCL-OH Specifications: 9mer peptide as TFA salt

  • EBV LMP2 426-434 Peptide (HLA-A*02:01) - CLGGLLTMV

    EBV LMP2 426-434 Peptide (HLA-A*02:01) – CLGGLLTMV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein 2 (LMP2) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-CLGGLLTMV-OH Specifications: 9mer peptide as TFA salt

  • EBV Lytic switch protein BZLF1  40-48, SQAPLPCVL

    EBV Lytic switch protein BZLF1 40-48, SQAPLPCVL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infectious mononucleosis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Lytic switch protein BZLF1 Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SQAPLPCVL-OH Specifications: 9mer peptide as TFA salt

  • EBV Lytic switch protein BZLF1  44-52, LPCVLWPVL

    EBV Lytic switch protein BZLF1 44-52, LPCVLWPVL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Lytic switch protein BZLF1 Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LPCVLWPVL-OH Specifications: 9mer peptide as TFA salt

  • EBV Lytic switch protein BZLF1  52-64, LPEPLPQGQLTAY

    EBV Lytic switch protein BZLF1 52-64, LPEPLPQGQLTAY

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Lytic switch protein BZLF1 Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LPEPLPQGQLTAY-OH Specifications: 13mer peptide as TFA salt

  • EBV mRNA export factor ICP27 homolog  417-425, DEVEFLGHY

    EBV mRNA export factor ICP27 homolog 417-425, DEVEFLGHY

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-DEVEFLGHY-OH Specifications: 9mer peptide as TFA salt

  • EBV Replication and transcription activator  198-206, TYPVLEEMF

    EBV Replication and transcription activator 198-206, TYPVLEEMF

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Replication and transcription activator (BRLF1) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TYPVLEEMF-OH Specifications: 9mer peptide as TFA salt

  • EEEV (Spike Glycoprotein E1)

    EEEV (Spike Glycoprotein E1)

    Amount: 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools Condition / Topic: Encephalitis, Fever, Infection Layout: Freeze-dried in glass vial Organism: Eastern Equine Encephalitis Virus (EEEV) Protein Name: Spike glycoprotein Purity: Development Grade: each peptide purified to > 70% (HPLC/MS)…

  • EEEV (Spike Glycoprotein E2)

    EEEV (Spike Glycoprotein E2)

    Amount: 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools Condition / Topic: Encephalitis, Fever, Infection Layout: Freeze-dried in glass vial Organism: Eastern Equine Encephalitis Virus (EEEV) Protein Name: Spike glycoprotein Purity: Development Grade: each peptide purified to > 70% (HPLC/MS)…

  • EF Pool

    EF Pool

    Amount: 15 nmol (approx. 25μg) / peptide for stimulation of 2,5 x 108 cells, 25 ug (approx. 15 nmol) / peptide for stimulation of 2,5 x 108 cells, 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Controls…